Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Lockner

Showing results (31-40 of 65) with videos related to

Pageof 7
Sort By:
Lakartidningen|May 13, 1970
[Erythroblastopenia--antibodies against erythroblasts?]S Franzén, D Lockner, P Reizenstein, et al.
Thrombosis and Haemostasis|April 22, 1985
A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragmentG Bratt, E Törnebohm, D Lockner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cellsC Paul, C Peterson, G Gahrton, et al.
Thrombosis Research|June 1, 1986
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersG Bratt, E Törnebohm, L Widlund, et al.
Clinical Immunology and Immunopathology|October 1, 1985
Kinetics of the spontaneously occurring common variable hypogammaglobulinemia: an analysis of two individuals with previously normal immunoglobulin levelsC I Smith, L Hammarström, M Lindahl, et al.
American Journal of Hematology|March 1, 1995
Alpha-2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosisE Törnebohm-Roche, M Merup, D Lockner, et al.
Acta Medica Scandinavica|January 1, 1986
Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinaseS Schulman, S Granqvist, A Juhlin-Dannfelt, et al.
Haemostasis|January 1, 1986
Intravenous and subcutaneous administration of Fragmin in deep venous thrombosisD Lockner, G Bratt, E Törnebohm, et al.
Thrombosis and Haemostasis|August 1, 1997
A 6-month venographic follow-up in 164 patients with acute deep vein thrombosisM Holmström, P Lindmarker, S Granqvist, et al.
Cancer|October 1, 1981
Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: report of three casesC Paul, B Lönnqvist, G Gahrton, et al.
Pageof 7

Showing results (31-40 of 65) with videos related to

Sort By:
Pageof 7
Lakartidningen|May 13, 1970
[Erythroblastopenia--antibodies against erythroblasts?]S Franzén, D Lockner, P Reizenstein, et al.
Thrombosis and Haemostasis|April 22, 1985
A human pharmacological study comparing conventional heparin and a low molecular weight heparin fragmentG Bratt, E Törnebohm, D Lockner, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1979
Uptake of free and DNA-bound daunorubicin and doxorubicin into human leukemic cellsC Paul, C Peterson, G Gahrton, et al.
Thrombosis Research|June 1, 1986
Low molecular weight heparin (KABI 2165, Fragmin): pharmacokinetics after intravenous and subcutaneous administration in human volunteersG Bratt, E Törnebohm, L Widlund, et al.
Clinical Immunology and Immunopathology|October 1, 1985
Kinetics of the spontaneously occurring common variable hypogammaglobulinemia: an analysis of two individuals with previously normal immunoglobulin levelsC I Smith, L Hammarström, M Lindahl, et al.
American Journal of Hematology|March 1, 1995
Alpha-2a interferon therapy and antibody formation in patients with essential thrombocythemia and polycythemia vera with thrombocytosisE Törnebohm-Roche, M Merup, D Lockner, et al.
Acta Medica Scandinavica|January 1, 1986
Long-term sequelae of calf vein thrombosis treated with heparin or low-dose streptokinaseS Schulman, S Granqvist, A Juhlin-Dannfelt, et al.
Haemostasis|January 1, 1986
Intravenous and subcutaneous administration of Fragmin in deep venous thrombosisD Lockner, G Bratt, E Törnebohm, et al.
Thrombosis and Haemostasis|August 1, 1997
A 6-month venographic follow-up in 164 patients with acute deep vein thrombosisM Holmström, P Lindmarker, S Granqvist, et al.
Cancer|October 1, 1981
Reducing the cardiotoxicity of anthracyclines by complex-binding to DNA: report of three casesC Paul, B Lönnqvist, G Gahrton, et al.
Pageof 7